263 related articles for article (PubMed ID: 8070325)
1. Percutaneous absorption, biotransformation, and systemic disposition of parathion in vivo in swine. I. Comprehensive pharmacokinetic model.
Qiao GL; Williams PL; Riviere JE
Drug Metab Dispos; 1994; 22(3):459-71. PubMed ID: 8070325
[TBL] [Abstract][Full Text] [Related]
2. Significant effects of application site and occlusion on the pharmacokinetics of cutaneous penetration and biotransformation of parathion in vivo in swine.
Qiao GL; Riviere JE
J Pharm Sci; 1995 Apr; 84(4):425-32. PubMed ID: 7629731
[TBL] [Abstract][Full Text] [Related]
3. Effects of anatomical site and occlusion on the percutaneous absorption and residue pattern of 2,6-[ring-14C]parathion in vivo in pigs.
Qiao GL; Chang SK; Riviere JE
Toxicol Appl Pharmacol; 1993 Sep; 122(1):131-8. PubMed ID: 8378927
[TBL] [Abstract][Full Text] [Related]
4. The use of mechanistically defined chemical mixtures (MDCM) to assess component effects on the percutaneous absorption and cutaneous disposition of topically exposed chemicals. I. Studies with parathion mixtures in isolated perfused porcine skin.
Qiao GL; Brooks JD; Baynes RE; Monteiro-Riviere NA; Williams PL; Riviere JE
Toxicol Appl Pharmacol; 1996 Dec; 141(2):473-86. PubMed ID: 8975772
[TBL] [Abstract][Full Text] [Related]
5. Pentachlorophenol dermal absorption and disposition from soil in swine: effects of occlusion and skin microorganism inhibition.
Qiao GL; Brooks JD; Riviere JE
Toxicol Appl Pharmacol; 1997 Dec; 147(2):234-46. PubMed ID: 9439719
[TBL] [Abstract][Full Text] [Related]
6. A physiologically based pharmacokinetic model of organophosphate dermal absorption.
van der Merwe D; Brooks JD; Gehring R; Baynes RE; Monteiro-Riviere NA; Riviere JE
Toxicol Sci; 2006 Jan; 89(1):188-204. PubMed ID: 16221965
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous penetration and absorption of parathion using human and pig skin models in vitro and human skin grafted onto nude mouse skin model in vivo.
Boudry I; Blanck O; Cruz C; Blanck M; Vallet V; Bazire A; Capt A; Josse D; Lallement G
J Appl Toxicol; 2008 Jul; 28(5):645-57. PubMed ID: 18041757
[TBL] [Abstract][Full Text] [Related]
8. Dermatoxicokinetic modeling of p-nitrophenol and its conjugation metabolite in swine following topical and intravenous administration.
Qiao GL; Chang SK; Brooks JD; Riviere JE
Toxicol Sci; 2000 Apr; 54(2):284-94. PubMed ID: 10774810
[TBL] [Abstract][Full Text] [Related]
9. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 5th communication: factors affecting percutaneous absorption in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Okamura Y; Kashiwazaki K; Takahashi N
Arzneimittelforschung; 1997 Mar; 47(3):270-5. PubMed ID: 9105545
[TBL] [Abstract][Full Text] [Related]
10. Quantitative percutaneous absorption and cutaneous distribution of binary mixtures of phenol and para-nitrophenol in isolated perfused porcine skin.
Brooks JD; Riviere JE
Fundam Appl Toxicol; 1996 Aug; 32(2):233-43. PubMed ID: 8921326
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous penetration and metabolism of 2-butoxyethanol.
Lockley DJ; Howes D; Williams FM
Arch Toxicol; 2004 Nov; 78(11):617-28. PubMed ID: 15455191
[TBL] [Abstract][Full Text] [Related]
12. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
13. Toward a better understanding of pesticide dermal absorption: diffusion model analysis of parathion absorption in vitro and in vivo.
Miller MA; Kasting GB
J Toxicol Environ Health A; 2010; 73(4):284-300. PubMed ID: 20077298
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous penetration and skin retention of topically applied compounds: an in vitro-in vivo study.
Reifenrath WG; Hawkins GS; Kurtz MS
J Pharm Sci; 1991 Jun; 80(6):526-32. PubMed ID: 1941541
[TBL] [Abstract][Full Text] [Related]
15. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
[TBL] [Abstract][Full Text] [Related]
16. A toxicokinetic model of malathion and its metabolites as a tool to assess human exposure and risk through measurements of urinary biomarkers.
Bouchard M; Gosselin NH; Brunet RC; Samuel O; Dumoulin MJ; Carrier G
Toxicol Sci; 2003 May; 73(1):182-94. PubMed ID: 12657741
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous absorption and metabolism of [14C]-ethoxycoumarin in a pig ear skin model.
Jacques C; Perdu E; Dorio C; Bacqueville D; Mavon A; Zalko D
Toxicol In Vitro; 2010 Aug; 24(5):1426-34. PubMed ID: 20417268
[TBL] [Abstract][Full Text] [Related]
18. Pimecrolimus: skin disposition after topical administration in minipigs in vivo and in human skin in vitro.
Gschwind HP; Waldmeier F; Zollinger M; Schweitzer A; Grassberger M
Eur J Pharm Sci; 2008 Jan; 33(1):9-19. PubMed ID: 17996430
[TBL] [Abstract][Full Text] [Related]
19. Disposition of parathion after dermal application in pigs.
Brimer L; Gyrd-Hansen N; Rasmussen F
J Vet Pharmacol Ther; 1994 Aug; 17(4):304-8. PubMed ID: 7966551
[TBL] [Abstract][Full Text] [Related]
20. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
